Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2003 Jun 24;10013:7476-9. doi: 10.1073/pnas.1330865100.
Show Gene links
Show Anatomy links
Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T, Eckstein-Ludwig U, Morin C, Krishna S.
???displayArticle.abstract???
Chemotherapy of malaria parasites is limited by established drug resistance and lack of novel targets. Intraerythrocytic stages of Plasmodium falciparum are wholly dependent on host glucose for energy. Glucose uptake is mediated by a parasite-encoded facilitative hexose transporter (PfHT). We report that O-3 hexose derivatives inhibit uptake of glucose and fructose by PfHT when expressed in Xenopus oocytes. Selectivity of these derivatives for PfHT is confirmed by lack of inhibition of hexose transport by the major mammalian glucose and fructose transporters (Gluts) 1 and 5. A long chain O-3 hexose derivative is the most effective inhibitor of PfHT and also kills P. falciparum when it is cultured in medium containing either glucose or fructose as a carbon source. To extend our observations to the second most important human malarial pathogen, we have cloned and expressed the Plasmodium vivax orthologue of PfHT, and demonstrate inhibition of glucose uptake by the long chain O-3 hexose derivative. Furthermore, multiplication of Plasmodium berghei in a mouse model is significantly reduced by the O-3 derivative. Our robust expression system conclusively validates PfHT as a novel drug target and is an important step in the development of novel antimalarials directed against membrane transport proteins.
Bignan,
Synthesis of 3-O-(iodoethyl)-D-glucose, a stable iodo derivative of D-glucose for medical imaging.
1993, Pubmed
Bignan,
Synthesis of 3-O-(iodoethyl)-D-glucose, a stable iodo derivative of D-glucose for medical imaging.
1993,
Pubmed BOURNE,
The methyl ethers of D-glucose.
1950,
Pubmed Corpe,
Cloning and functional characterization of the mouse fructose transporter, GLUT5.
2002,
Pubmed
,
Xenbase Gardner,
Genome sequence of the human malaria parasite Plasmodium falciparum.
2002,
Pubmed Ikekawa,
Studies on synthesis of 3-O-alkyl-D-glucose and 3-O-alkyl-D-allose derivatives and their biological activities.
1987,
Pubmed Joët,
Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
2002,
Pubmed
,
Xenbase Kirk,
Membrane transport in the malaria-infected erythrocyte.
2001,
Pubmed Krishna,
Hexose transport in asexual stages of Plasmodium falciparum and kinetoplastidae.
2000,
Pubmed Krishna,
Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets.
2002,
Pubmed
,
Xenbase Manning,
Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
2002,
Pubmed
,
Xenbase Ridley,
Medical need, scientific opportunity and the drive for antimalarial drugs.
2002,
Pubmed ter Kuile,
Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.
1993,
Pubmed Thaithong,
Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests.
1981,
Pubmed Woodrow,
Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
1999,
Pubmed
,
Xenbase Woodrow,
Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
2000,
Pubmed
,
Xenbase Zeller,
Synthesis and mass spectra of 4-O-acetyl-1,5-anhydro-2,3,6-tri-O-ethyl-D-glucitol and the positional isomers of 4-O-acetyl-1,5-anhydro-di-O-ethyl-O- methyl-D-glucitol and 4-O-acetyl-1,5-anhydro-O-ethyl-di-O-methyl-D-glucitol.
1988,
Pubmed
